全文获取类型
收费全文 | 1831篇 |
免费 | 141篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 52篇 |
妇产科学 | 24篇 |
基础医学 | 317篇 |
口腔科学 | 14篇 |
临床医学 | 268篇 |
内科学 | 317篇 |
皮肤病学 | 68篇 |
神经病学 | 227篇 |
特种医学 | 45篇 |
外科学 | 185篇 |
综合类 | 10篇 |
预防医学 | 177篇 |
眼科学 | 13篇 |
药学 | 98篇 |
中国医学 | 4篇 |
肿瘤学 | 140篇 |
出版年
2023年 | 20篇 |
2022年 | 12篇 |
2021年 | 37篇 |
2020年 | 43篇 |
2019年 | 64篇 |
2018年 | 50篇 |
2017年 | 37篇 |
2016年 | 54篇 |
2015年 | 69篇 |
2014年 | 72篇 |
2013年 | 88篇 |
2012年 | 150篇 |
2011年 | 163篇 |
2010年 | 99篇 |
2009年 | 50篇 |
2008年 | 113篇 |
2007年 | 147篇 |
2006年 | 96篇 |
2005年 | 122篇 |
2004年 | 90篇 |
2003年 | 80篇 |
2002年 | 107篇 |
2001年 | 8篇 |
2000年 | 7篇 |
1999年 | 19篇 |
1998年 | 8篇 |
1997年 | 15篇 |
1996年 | 12篇 |
1995年 | 13篇 |
1994年 | 6篇 |
1993年 | 12篇 |
1992年 | 8篇 |
1991年 | 8篇 |
1990年 | 5篇 |
1989年 | 7篇 |
1988年 | 7篇 |
1987年 | 7篇 |
1986年 | 6篇 |
1985年 | 5篇 |
1984年 | 7篇 |
1983年 | 3篇 |
1982年 | 7篇 |
1981年 | 4篇 |
1977年 | 4篇 |
1972年 | 2篇 |
1967年 | 2篇 |
1964年 | 4篇 |
1960年 | 3篇 |
1956年 | 2篇 |
1955年 | 2篇 |
排序方式: 共有1979条查询结果,搜索用时 218 毫秒
1.
Peter D. Baade David C. Whiteman Monika Janda Anne E. Cust Rachel E. Neale Bernard Mark Smithers Adele C. Green Kiarash Khosrotehrani Victoria Mar H. Peter Soyer Joanne F. Aitken 《International journal of cancer. Journal international du cancer》2020,147(5):1391-1396
There is little long-term follow-up information about how the number of melanoma deaths and case fatality vary over time according to the measured thickness of melanoma at diagnosis. This population-based longitudinal cohort study examines patterns and trends in case fatality among 44,531 people in Queensland (Australia) diagnosed with a single invasive melanoma (International Classification of Diseases for Oncology, third revision [ICD-O-3], C44, Morphology 872–879) between 1987 and 2011, including 11,883 diagnosed between 1987 and 1996, with up to 20 years follow-up (to December 2016). The 20-year case fatality increased by thickness, with the percentage of melanoma deaths within 20 years of diagnosis being up to 4.8% for melanomas with measured thickness <0.80 mm, 10.6% for tumors 0.8 to <1.0 mm and generally more than 30% for melanomas measuring 3 mm and more. For melanomas <1.0 mm, most deaths occurred between 5 and 20 years after diagnosis, whereas for thicker melanomas the reverse was true with most deaths occurring within the first 5 years. Five-year case fatality decreased over successive calendar time periods for melanomas <1.0 mm, but not for melanomas ≥1.0 mm. These findings demonstrate that the time course for fatal melanomas varies markedly according to tumor thickness at diagnosis. Improved understanding of the patient factors and characteristics of melanomas, in addition to tumor thickness, which increase the likelihood of progression, is needed to guide clinical diagnosis, communication with patients and ongoing surveillance pathways of patients with potentially fatal lesions. 相似文献
2.
3.
4.
5.
There has been a significant increase in the past few decades in the number of children receiving noninvasive positive airway pressure (PAP) therapy at home. At present, PAP therapy can be successfully used in children of all ages, for a variety of indications. Data acquired from PAP devices is clinically useful, providing objective information regarding adherence, leak, and efficacy of PAP therapy. However, guidelines outlining a standardized approach to interpretation of PAP device data in pediatrics is currently lacking. Given the rapidly expanding use of PAP therapy in pediatric practice, we aim to provide an overview of the interpretation of data reports, otherwise called “data downloads,” from PAP devices and illustrate how they can be used to guide clinical care. 相似文献
6.
7.
8.
Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long‐term follow‐up of a large series 下载免费PDF全文
9.
Verdelis K Lukashova L Yamauchi M Atsawasuwan P Wright JT Peterson MG Jha D Boskey AL 《European journal of oral sciences》2007,115(4):296-302
Phosphorylation of the organic matrix proteins of dentin is important for the initiation of mineralization, but its relevance in later mineralization stages is controversial. The objective of this study was to analyze changes in the total matrix phosphate content during dentin development and to identify their origin. Amino acid and total matrix phosphate analyses of microdissected developing mantle and circumpulpal fetal bovine dentin specimens were performed. The amino acid composition showed few changes during mantle and circumpulpal dentin maturation. However, the total matrix phosphate content showed a significant, positive correlation with tissue maturation in both mantle and circumpulpal dentin, with a two- and a three-fold increase, respectively, being observed. The data indicate that changes occur in the pattern of phosphorylation of matrix proteins during dentin maturation, which we suggest may play a functional role in later stages of tooth mineralization. 相似文献
10.
Simon Tremblay James J. Driscoll Adele Rike‐Shields David A. Hildeman Rita R. Alloway Alin L. Girnita Paul A. Brailey E. Steve Woodle 《American journal of transplantation》2020,20(2):411-421
Proteasome inhibitor–based strategies hold promise in transplant but have yielded varying results. Carfilzomib, a second‐generation proteasome inhibitor, may possess advantages over bortezomib, the first‐generation proteasome inhibitors. The purpose of this study was to evaluate the safety, toxicity, and preliminary efficacy of carfilzomib in highly HLA‐sensitized kidney transplant candidates. Renal transplant candidates received escalating doses of carfilzomib followed by plasmapheresis (group A) or an identical regimen with additional plasmapheresis once weekly before carfilzomib dosing. Thirteen participants received carfilzomib, which was well tolerated with most adverse events classified as low grade. The safety profile was similar to bortezomib desensitization; however, neurotoxicity was not observed with carfilzomib. Toxicity resulted in permanent dose reduction in 1 participant but caused no withdrawals or deaths. HLA antibodies were substantially reduced with carfilzomib alone, and median maximal immunodominant antibody reduction was 72.8% (69.8% for group A, P = .031, 80.1% for group B, P = .938). After depletion, rebound occurred rapidly and antibody levels returned to baseline between days 81 and 141. Bone marrow studies revealed that approximately 69.2% of plasma cells were depleted after carfilzomib monotherapy. Carfilzomib monotherapy–based desensitization provides an acceptable safety and toxicity profile while leading to significant bone marrow plasma cell depletion and anti‐HLA antibody reduction. 相似文献